(BZH) Beazer Homes USA - Ratings and Ratios
Single-Family Homes, Multi-Family Homes, Gatherings, Choice Plans
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 51.0% |
| Value at Risk 5%th | 73.8% |
| Relative Tail Risk | -12.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -44.70 |
| CAGR/Max DD | 0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.464 |
| Beta | 1.038 |
| Beta Downside | 0.680 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.79% |
| Mean DD | 20.19% |
| Median DD | 19.05% |
Description: BZH Beazer Homes USA October 22, 2025
Beazer Homes USA, Inc. (NYSE:BZH) is a U.S. homebuilder that designs, constructs, and sells both single-family and multifamily residences under the Beazer Homes, Gatherings, and Choice Plans brands. Sales are executed through a network of commissioned new-home sales counselors and independent brokers across 13 states, including high-growth markets such as Texas, Florida, and California. The company was founded in 1985 and is headquartered in Atlanta, Georgia.
As of Q3 2024, BZH reported a backlog of roughly 2,300 homes and an average selling price (ASP) of $425 k, reflecting a 7% year-over-year increase driven by rising construction costs and limited inventory. The homebuilding sector remains highly sensitive to mortgage-rate movements; the current 30-year fixed rate of ~6.8% is above the 5-year average, pressuring affordability and potentially tempering demand. Additionally, regional labor shortages in the Southwest and supply-chain constraints on lumber and steel continue to affect delivery timelines and margins.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of BZH’s valuation metrics, peer comparisons, and scenario-based forecasts that can help you assess the trade-off between growth potential and risk exposure.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (45.6m TTM) > 0 and > 6% of Revenue (6% = 142.3m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 6.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 89.46% (prev 93.74%; Δ -4.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.07 (>3.0%) and CFO -186.2m <= Net Income 45.6m (YES >=105%, WARN >=100%) |
| Net Debt (842.2m) to EBITDA (67.9m) ratio: 12.41 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.38 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.3m) change vs 12m ago -5.22% (target <= -2.0% for YES) |
| Gross Margin 14.69% (prev 18.16%; Δ -3.47pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 91.19% (prev 89.92%; Δ 1.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.21 (EBITDA TTM 67.9m / Interest Expense TTM 7.84m) >= 6 (WARN >= 3) |
Altman Z'' 6.32
| (A) 0.81 = (Total Current Assets 2.33b - Total Current Liabilities 204.5m) / Total Assets 2.61b |
| (B) 0.16 = Retained Earnings (Balance) 423.8m / Total Assets 2.61b |
| (C) 0.02 = EBIT TTM 48.7m / Avg Total Assets 2.60b |
| (D) 0.31 = Book Value of Equity 423.8m / Total Liabilities 1.36b |
| Total Rating: 6.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.33
| 1. Piotroski 2.50pt |
| 2. FCF Yield 0.23% |
| 3. FCF Margin 0.15% |
| 4. Debt/Equity 0.85 |
| 5. Debt/Ebitda 12.41 |
| 6. ROIC - WACC (= -2.14)% |
| 7. RoE 3.70% |
| 8. Rev. Trend 28.54% |
| 9. EPS Trend -54.99% |
What is the price of BZH shares?
Over the past week, the price has changed by +0.36%, over one month by +3.67%, over three months by -14.01% and over the past year by -28.61%.
Is BZH a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BZH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.8 | 31.8% |
| Analysts Target Price | 29.8 | 31.8% |
| ValueRay Target Price | 22.5 | -0.3% |
BZH Fundamental Data Overview December 08, 2025
P/E Trailing = 14.8026
P/E Forward = 22.6757
P/S = 0.2823
P/B = 0.5678
P/EG = 1.1348
Beta = 2.167
Revenue TTM = 2.37b USD
EBIT TTM = 48.7m USD
EBITDA TTM = 67.9m USD
Long Term Debt = 1.03b USD (from longTermDebt, last quarter)
Short Term Debt = 1.16m USD (from shortTermDebt, two quarters ago)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 842.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.51b USD (669.6m + Debt 1.06b - CCE 214.7m)
Interest Coverage Ratio = 6.21 (Ebit TTM 48.7m / Interest Expense TTM 7.84m)
FCF Yield = 0.23% (FCF TTM 3.48m / Enterprise Value 1.51b)
FCF Margin = 0.15% (FCF TTM 3.48m / Revenue TTM 2.37b)
Net Margin = 1.92% (Net Income TTM 45.6m / Revenue TTM 2.37b)
Gross Margin = 14.69% ((Revenue TTM 2.37b - Cost of Revenue TTM 2.02b) / Revenue TTM)
Gross Margin QoQ = 13.49% (prev 15.20%)
Tobins Q-Ratio = 0.58 (Enterprise Value 1.51b / Total Assets 2.61b)
Interest Expense / Debt = 1.06% (Interest Expense 11.2m / Debt 1.06b)
Taxrate = -15.30% (negative due to tax credits) (-3.98m / 26.0m)
NOPAT = 56.1m (EBIT 48.7m * (1 - -15.30%)) [negative tax rate / tax credits]
Current Ratio = 11.38 (Total Current Assets 2.33b / Total Current Liabilities 204.5m)
Debt / Equity = 0.85 (Debt 1.06b / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = 12.41 (Net Debt 842.2m / EBITDA 67.9m)
Debt / FCF = 242.0 (Net Debt 842.2m / FCF TTM 3.48m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.75% (Net Income 45.6m / Total Assets 2.61b)
RoE = 3.70% (Net Income TTM 45.6m / Total Stockholder Equity 1.23b)
RoCE = 2.15% (EBIT 48.7m / Capital Employed (Equity 1.23b + L.T.Debt 1.03b))
RoIC = 2.43% (NOPAT 56.1m / Invested Capital 2.31b)
WACC = 4.56% (E(669.6m)/V(1.73b) * Re(9.84%) + D(1.06b)/V(1.73b) * Rd(1.06%) * (1-Tc(-0.15)))
Discount Rate = 9.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.69%
[DCF Debug] Terminal Value 62.80% ; FCFE base≈3.48m ; Y1≈2.28m ; Y5≈1.04m
Fair Price DCF = 0.53 (DCF Value 15.7m / Shares Outstanding 29.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -54.99 | EPS CAGR: -1.39% | SUE: 1.18 | # QB: 1
Revenue Correlation: 28.54 | Revenue CAGR: 15.98% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.122 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-09-30): EPS=1.44 | Chg30d=-0.462 | Revisions Net=-1 | Growth EPS=-24.6% | Growth Revenue=+4.3%
EPS next Year (2027-09-30): EPS=2.93 | Chg30d=-0.243 | Revisions Net=-1 | Growth EPS=+104.0% | Growth Revenue=+8.7%
Additional Sources for BZH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle